Unraveling the Nature of Antibiotics: Is It a Cure or a New Hurdle to the Patient Treatment?
- PMID: 35547462
- PMCID: PMC9085652
- DOI: 10.7759/cureus.23955
Unraveling the Nature of Antibiotics: Is It a Cure or a New Hurdle to the Patient Treatment?
Abstract
Antimicrobial resistance is an increasing problem worldwide that has been exacerbated by antibiotic misuse worldwide. Growing antibiotic resistance can be attributed to as well as leads to severe infections, complications, prolonged hospital admissions, and higher mortality. One of the most important goals of administering antimicrobials is to avoid establishing antibiotic resistance during therapy. This can be done by drastically lowering worldwide antimicrobial usage, both in present and future. While current management methods to legislate antimicrobials and educate the healthcare community on the challenges are beneficial, they do not solve the problem of attaining an overall reduction in antimicrobial usage in humans. Application of rapid microbiological diagnostics for identification and antimicrobial susceptibility testing, use of inflammation markers to guide initiation and duration of therapies, reduction of standard antibiotic course durations, individualization of antibiotic treatments, and dosing considering pharmacokinetics are all possible strategies to optimize antibiotic use in everyday clinical practice and reduce the risk of inducing bacterial resistance. Furthermore, to remove any impediments to proper prescribing, strategies to improve antibiotic prescribing and antibiotic stewardship programs should enable clinical reasoning and enhance the prescribing environment. In addition, the well-established association between antimicrobial usage and resistance should motivate efforts to develop antimicrobial treatment regimens that facilitate the evolution of resistance. This review discusses the role of antibiotics, their current application in human medicine, and how the resistance has evolved to the existing antibiotics based on the existing literature.
Keywords: antibiotic stewardship programs; antimicrobial resistance; antimicrobial susceptibility testing; rapid microbial diagnostics; rational use of antibiotics.
Copyright © 2022, Gude et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Optimizing antibiotic therapies to reduce the risk of bacterial resistance.Eur J Intern Med. 2022 May;99:7-12. doi: 10.1016/j.ejim.2022.01.029. Epub 2022 Jan 21. Eur J Intern Med. 2022. PMID: 35074246 Review.
-
[Proper antibiotic therapy. From penicillin to pharmacogenomic].Minerva Pediatr. 2012 Apr;64(2):225-37. Minerva Pediatr. 2012. PMID: 22495196 Review. Italian.
-
Inappropriate use of antibiotics in hospitals: the complex relationship between antibiotic use and antimicrobial resistance.Enferm Infecc Microbiol Clin. 2013 Sep;31 Suppl 4:3-11. doi: 10.1016/S0213-005X(13)70126-5. Enferm Infecc Microbiol Clin. 2013. PMID: 24129283
-
Enhancing the empiric antibiotic selection by introducing an antibiogram toolkit in a tertiary care hospital in Southern India - A prospective study.J Clin Pharm Ther. 2022 Apr;47(4):507-516. doi: 10.1111/jcpt.13571. Epub 2021 Dec 28. J Clin Pharm Ther. 2022. PMID: 34962298
-
Antimicrobial stewardship: bridging the gap between quality care and cost.Curr Opin Infect Dis. 2011 Feb;24 Suppl 1:S11-20. doi: 10.1097/01.qco.0000393484.17894.05. Curr Opin Infect Dis. 2011. PMID: 21200180 Review.
References
-
- Emergence of global antibiotic resistance. Morehead MS, Scarbrough C. Prim Care. 2018;45:467–484. - PubMed
-
- Antibiotic stewardship: strategies to minimize antibiotic resistance while maximizing antibiotic effectiveness. Cunha CB, Opal SM. Med Clin North Am. 2018;102:831–843. - PubMed
-
- Optimizing antibiotic therapies to reduce the risk of bacterial resistance [PREPRINT] Bassetti S, Tschudin-Sutter S, Egli A, Osthoff M. Eur J Intern Med. 2022 - PubMed
Publication types
LinkOut - more resources
Full Text Sources